These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Clinical tolerance of corticospinal tracts in convection-enhanced delivery to the brainstem. Morgenstern PF; Zhou Z; Wembacher-Schröder E; Cina V; Tsiouris AJ; Souweidane MM J Neurosurg; 2019 Dec; 131(6):1812-1818. PubMed ID: 30579270 [TBL] [Abstract][Full Text] [Related]
26. Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models. Jansen MH; Lagerweij T; Sewing AC; Vugts DJ; van Vuurden DG; Molthoff CF; Caretti V; Veringa SJ; Petersen N; Carcaboso AM; Noske DP; Vandertop WP; Wesseling P; van Dongen GA; Kaspers GJ; Hulleman E Mol Cancer Ther; 2016 Sep; 15(9):2166-74. PubMed ID: 27325687 [TBL] [Abstract][Full Text] [Related]
27. Convection Enhanced Delivery for Diffuse Intrinsic Pontine Glioma: Review of a Single Institution Experience. Tosi U; Souweidane M Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32674336 [TBL] [Abstract][Full Text] [Related]
28. Longitudinal Monitoring of Gd-DTPA Following Convection Enhanced Delivery in the Brainstem. Tosi U; Souweidane MM World Neurosurg; 2020 May; 137():38-42. PubMed ID: 32028001 [TBL] [Abstract][Full Text] [Related]
29. A Novel Methodology for Applying Multivoxel MR Spectroscopy to Evaluate Convection-Enhanced Drug Delivery in Diffuse Intrinsic Pontine Gliomas. Guisado DI; Singh R; Minkowitz S; Zhou Z; Haque S; Peck KK; Young RJ; Tsiouris AJ; Souweidane MM; Thakur SB AJNR Am J Neuroradiol; 2016 Jul; 37(7):1367-73. PubMed ID: 26939629 [TBL] [Abstract][Full Text] [Related]
31. Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential Candidates. El-Khouly FE; van Vuurden DG; Stroink T; Hulleman E; Kaspers GJL; Hendrikse NH; Veldhuijzen van Zanten SEM Front Oncol; 2017; 7():254. PubMed ID: 29164054 [TBL] [Abstract][Full Text] [Related]
32. Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma. Zhao G; Newbury P; Ishi Y; Chekalin E; Zeng B; Glicksberg BS; Wen A; Paithankar S; Sasaki T; Suri A; Nazarian J; Pacold ME; Brat DJ; Nicolaides T; Chen B; Hashizume R Acta Neuropathol Commun; 2022 Oct; 10(1):150. PubMed ID: 36274161 [TBL] [Abstract][Full Text] [Related]
33. OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma. Thomas L; Smith N; Saunders D; Zalles M; Gulej R; Lerner M; Fung KM; Carcaboso AM; Towner RA J Transl Med; 2020 Nov; 18(1):424. PubMed ID: 33168005 [TBL] [Abstract][Full Text] [Related]
34. Development of a clinical scale for assessment of patients with diffuse intrinsic pontine glioma (DIPG) receiving experimental therapy: the PONScore. Hollingworth MA; Zacharoulis S J Neurooncol; 2020 Sep; 149(2):263-272. PubMed ID: 32902768 [TBL] [Abstract][Full Text] [Related]
35. T2-weighted images are superior to other MR image types for the determination of diffuse intrinsic pontine glioma intratumoral heterogeneity. Harward S; Harrison Farber S; Malinzak M; Becher O; Thompson EM Childs Nerv Syst; 2018 Mar; 34(3):449-455. PubMed ID: 29151166 [TBL] [Abstract][Full Text] [Related]
36. Functionalized Macrophage Exosomes with Panobinostat and PPM1D-siRNA for Diffuse Intrinsic Pontine Gliomas Therapy. Shan S; Chen J; Sun Y; Wang Y; Xia B; Tan H; Pan C; Gu G; Zhong J; Qing G; Zhang Y; Wang J; Wang Y; Wang Y; Zuo P; Xu C; Li F; Guo W; Xu L; Chen M; Fan Y; Zhang L; Liang XJ Adv Sci (Weinh); 2022 Jul; 9(21):e2200353. PubMed ID: 35585670 [TBL] [Abstract][Full Text] [Related]
37. Development of a human in vitro blood-brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance. Deligne C; Hachani J; Duban-Deweer S; Meignan S; Leblond P; Carcaboso AM; Sano Y; Shimizu F; Kanda T; Gosselet F; Dehouck MP; Mysiorek C Fluids Barriers CNS; 2020 Jun; 17(1):37. PubMed ID: 32487241 [TBL] [Abstract][Full Text] [Related]